Business Daily from THE HINDU group of publications
Sunday, Jun 08, 2008
ePaper | Mobile/PDA Version | Audio
Business Daily from THE HINDU group of publications Sunday, Jun 08, 2008 ePaper | Mobile/PDA Version | Audio |
|
|
|
|
|
|
|
Corporate
-
Dividend Announcement Corporate Results - Pharmaceuticals Markets - Stocks 
Our Bureau Hyderabad, June 7 Active Pharmaceutical Ingredients (APIs) and intermediaries manufacturer Divi’s Laboratories Ltd’s net profit decreased by 5 per cent to Rs 94.37 crore in the fourth quarter ended March 31, 2008 compared with Rs 101 crore in the corresponding period of the previous fiscal. Total income, however, increased to Rs 282.51 crore (Rs 256 crore). For 2007-08, the Hyderabad-based company’s net profit increased 87 per cent to Rs 348 crore (Rs 185.8 crore) driven by 43 per cent growth in sales at Rs 1,047 crore. The increase in other expenses driven by Rs 9.88 crore loss due to forex fluctuation impacted profitability during the quarter under review. To pay 200%The board of directors recommended a dividend of 200 per cent on the equity shares subject to the approval of members, according to a release. During the period under review, Divi’s spent Rs 176 crore on capital expenditure for augmenting capacities at its units. Its new nutraceuticals manufacturing facility was commissioned on June 1, 2008, the release added. More Stories on : Dividend Announcement | Pharmaceuticals | Stocks
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
 |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2008, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|